Physician profile
William A Stefani
NPI 1447266945
$5,324.23
in general payments reported to CMS, 2019-2025
23 companies · $3,316 in 2025
The $3,316 reported for 2025 was more than what 90% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $702 · 2020: $37.75 · 2021: $413 · 2022: $152 · 2023: $253 · 2024: $451 · 2025: $3,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,894 · Long Term Medical Supply Or Device Loan: $1,189 · Travel and Lodging: $937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,894.26 |
| Long Term Medical Supply Or Device Loan | $1,188.71 |
| Travel and Lodging | $936.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,543.08 | 2023-2025 | Avance Nerve Graft |
| Integra Lifesciences Corporation | $1,284.39 | 2025 | Durasorb Monofilament Mesh, Integra, Omnigraft |
| Mentor Worldwide LLC | $608.27 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $355.77 | 2019-2022 | |
| Revance Therapeutics, INC. | $270.57 | 2024-2025 | Daxxify |
| Abbvie INC. | $230.06 | 2023-2025 | Alloderm |
| Merz North America, INC. | $209.28 | 2019 | |
| Stryker Corporation | $172.13 | 2019-2025 | Dermacell, Spy-Phi System |
| Rti Surgical, INC | $114.15 | 2025 | |
| Bard Peripheral Vascular, INC. | $101.40 | 2021 | |
| Biocomposites INC | $95.00 | 2019 | |
| Tela Bio, INC. | $69.59 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Galderma Laboratories, L.P. | $58.32 | 2019-2025 | Dysport |
| Mimedx Group, INC. | $32.07 | 2025 | |
| Convatec INC. | $29.91 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $29.35 | 2021 | |
| Solventum Corporation | $29.01 | 2025 | Prevena |
| Ets Wound Care LLC | $24.94 | 2024 | Mirragen Advanced Wound Matrix |
| Biocircuit Technologies INC | $22.31 | 2025 | Nerve Tape |
| Smith+Nephew, INC. | $16.63 | 2025 | Pico 7 |
| Vertex Pharmaceuticals Incorporated | $14.36 | 2025 | |
| Motiva USA, LLC | $13.64 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Stefani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.